12-Month Outcomes From A Randomised Sham Controlled Study Evaluating The Optilume Bph System

12-month outcomes from a randomised sham controlled study evaluating the Optilume BPH System

European Association of Urology

#22927 A Randomized Controlled Trial Evaluating the Optilume Urethral Drug Coated Balloon vs End...

Optilume for BPH - Considerations for Use

Grand Rounds in Urology

Optilume® BPH Catheter System - Optilume® BPH Product and Clinical Data Overview

Grand Rounds in Urology

Optilume® BPH Catheter System Data from the PINNACLE Trial in the September 2023 Journal of Urology

Grand Rounds in Urology

Optilume BPH Catheter System Starburst Animation Video

Laborie Urology & Urogynecology

Surgical Treatment of Benign Prostatic Hyper-plasia: A Review of the 2018 AUA Guidelines

Grand Rounds in Urology

91: Using a Drug-Coated Balloon to Treat Benign Enlargement of the Prostate – Steven Kaplan,...

Garrett D. Pohlman M.D.

Episode 55: Optilume, a New Treatment Option for BPH

BPH Treatments: HoLEP, PAE, Surgical, TURPs, & More | Casey Dauw, MD & Q+A with #MarkMoyadMD| #PCRI

Prostate Cancer Research Institute

Speedy and Effective Diagnostic Pathway for Prostate Cancer

BJUI

Optilume BPH

Treating BPH: Comparing Treatment Modalities

Grand Rounds in Urology

PSMs in RP patients do not predict long-term oncological outcomes

BJUI

LuPARP: 177Lu-PSMA-617 and PARP inhibitor combination for prostate cancer

Results of Phase I Study Reach Primary End Point for mCRPC

Targeted Oncology

Understanding the pathways behind selective mitophagy upregulation

Fall 2021, Systematic Review Series #6, Screening Articles

Himmelfarb Health Sciences Library

PAD Patient Consultsulation Overview

Tissue acquisition and reflex testing: How do we prioritize?